The era of in vivo T cell engineering

Engineering ex vivo T-cell expansion for CAR-T therapy: bridging biological fidelity and bioprocess scalability through platforms, functional consumables, and integrated closed manufacturing
Qingzhi Wu, Menghui Jiang, Yuanyuan Li +10
Frontiers in Immunology20 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
Evolution of CAR-T Therapy: Functional Engineering, Manufacturing Innovation, and Future In Vivo Strategies.
Yukimi Sakoda
Cancer science18 Oct 2026Peer-reviewedCC BY-NCFull textOncologyEurope PMC
Evaluation of the Clinical Usefulness of a Bioartificial Urethral Substitute Generated by Tissue Engineering in Laboratory Rabbits: Protocol for an In Vivo Study
David Sánchez-Porras, Fernando Campos, Jesús Chato-Astrain +3
JMIR Research Protocols20 Oct 2026Peer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
Advancing the Translational Pipeline: From In Vivo and In Vitro 2D Models to Next-Generation Cell Culture Models for Amyotrophic Lateral Sclerosis Modelling and Drug Discovery
Elisabetta Carata, Stefania Mariano, Bernardetta Anna Tenuzzo +1
Biomedicines1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Ex-vivo 7T MRI for accurate margin assessment in oral squamous cell carcinoma surgery
J. Guichelaar, R. van der Woude, K. J. de Koning +6
medRxiv12 Oct 2026PreprintAll rights reservedFull textMedical imaging & radiologymedRxiv

Cite

BibTeX

@article{ramos2026vivo,
  title = {{The era of in vivo T cell engineering}},
  author = {Gustavo Campos Ramos and Michael Hudecek},
  journal = {Med},
  year = {2026},
  month = oct,
  doi = {10.1016/j.medj.2022.01.012},
  url = {https://hal.science/hal-05780858v1},
}

RIS

TY  - JOUR
TI  - The era of in vivo T cell engineering
AU  - Gustavo Campos Ramos
AU  - Michael Hudecek
PY  - 2026
DA  - 2026/10/06
JO  - Med
DO  - 10.1016/j.medj.2022.01.012
UR  - https://hal.science/hal-05780858v1
SN  - 2666-6340
ER  -

Related

Cite